Newsletter | February 26, 2020

02.26.20 -- 4 Questions AbbVie Asked To Create More Diverse Clinical Trials

Focus On Patients
4 Questions AbbVie Asked To Create More Diverse Clinical Trials
By Charlotte Owens, M.D., AbbVie

Over the five years I have been at AbbVie, the idea of diversity and inclusivity in healthcare was especially relevant to our clinical trials in uterine fibroids. We successfully centered patients in our program by understanding their needs, concerns, and desires, which enabled us to recruit and retain women representative of the patient landscape in this disease state. How? We asked ourselves four important questions.

Twitter Takeovers: Forging Stronger Connections With Patient Communities
By Nerissa Kreher, M.D., chief medical officer, Tiburio Therapeutics

Learn how Tiburio Therapeutics is using Twitter takeovers, advocacy outreach, and collaboration on social media to enhance the company’s efforts to accurately capture the patient’s voice and ensure it is incorporated into future trial designs.

Industry Insights
CRO Selection Taken Seriously
Article | By Rebecca McAvoy, ISR Reports

Industry Standard Research (ISR) asked over 500 clinical development outsourcers their level of agreement with the statement: My organization’s mix of CROs is not likely to change much in the next two years.

5 IRT Trends To Watch
Article | By Justin Jaeschke and Bryan Clayton, YPrime

Next generation IRT continues to evolve from work horse to racehorse – with the power to keep pace with rising clinical trial complexity and efficiency demands. Following are five IRT trends and how they will affect the clinical trial landscape.

Don’t Let Burdensome Site Payment Processes Undermine Your Study Performance
Article | By Dave Espenshade, Greenphire

CROs and sponsors: Have we overcome the limitations of early site payment solutions? Learn how a site payment advisory group helped improve site payment technology for all stakeholders.

5 Key KPIs Every Disclosure Team Should Monitor: And Why
Article | By Darcy Grabenstein, TrialScope

Like any department within a pharmaceutical organization, clinical trial disclosure teams contribute to the bottom line and must be accountable. Here are five key performance indicators (KPIs) to monitor on a regular basis.

Phase 3 Rare Disease Rescue
Case Study | Catalyst Clinical Research

A small biotech with limited internal capacity outsourced a Phase 3 clinical program in patients with necrotizing soft tissue infections. After nearly 16 months patient enrollment was still a major challenge, the study was over budget, and CRO staff turnover on the project was extremely high.

eConsent In Action: How It Works And Why Patients Appreciate It
Webinar | Signant Health

Do you have questions regarding eConsent such as: Can I afford it? What is the measured ROI? How does it change the ICF creation process? Does it work globally? Watch this 45-minute webinar for the answers you need.

Understanding Common Causes Of Failure In Depression Studies
Webinar | Rho

Dr. Jack Modell discusses why there is more to the story than placebo response in regard to the high failure rate of clinical studies in depression. Identify other factors that can contribute to failures and what steps can be taken to avoid those pitfalls.

  Clinical Research As A Care Option (CRAACO)

Clinical Research as a Care Option (CRAACO) on April 27 and 28, 2020, in Raleigh, NC, will gather the clinical research and healthcare communities together to address the value, opportunities, and challenges to integrating clinical research and clinical care for the benefit of patients. CRAACO will demonstrate examples from over 20 healthcare systems nationwide on best practices in working with industry.

Clinical Supply Chain Management
Almac Group
Hematology Oncology
Premier Research
Speed To Study
PCI Clinical Services
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With Clinical Leader: